Results 291 to 300 of about 12,776,407 (326)

Non-anticoagulant effects of low molecular weight heparins in inflammatory disorders: A review

Carbohydrate Polymers, 2017
Xin-Hui Xing, Shanshan Du
exaly  

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

Journal of Clinical Oncology, 2004
A. Kakkar, M. Levine, Z. Kadziola, N. Lemoine, Vanessa Low, H. Patel, G. Rustin, Michael Thomas, M. Quigley, R. Williamson   +9 more
semanticscholar   +1 more source

Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction

Thrombosis Research, 1982
C J Carter, L Mitchell, J Hirsh
exaly  

Heparin/low molecular weight heparins

Reactions Weekly, 2012
openaire   +1 more source

Ultrasonic-assisted preparation of a low molecular weight heparin (LMWH) with anticoagulant activity

Carbohydrate Polymers, 2013
Frédéric Sannier, Thierry Maugard, Nicolas Bridiau   +2 more
exaly  

A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparation

Thrombosis Research, 1984
Michael R Buchanan, A L Cerskus, M R Buchanan   +2 more
exaly  

Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin

Thrombosis and Haemostasis, 2006
Shaker A Mousa, Robert J. Linhardt, John L Francis   +2 more
exaly  

Heparin and low-molecular weight heparins

Coronary Artery Disease, 1992
openaire   +1 more source

Low molecular weight heparin in children

European Journal of Pediatrics, 2001
Manuela Albisetti, Maureen Andrew
exaly  

Heparin and low-molecular-weight heparins modulate the decidualization of human endometrial stromal cells

Fertility and Sterility, 2010
Herbert Fluhr, Julia Spratte, Peter Licht   +2 more
exaly